• Why developing nerve cells can take a wr

    From ScienceDaily@1337:3/111 to All on Wed Jun 3 22:28:04 2020
    Why developing nerve cells can take a wrong turn

    Date:
    June 3, 2020
    Source:
    University of Cologne
    Summary:
    Loss of ubiquitin-conjugating enzyme leads to impediment in growth
    of nerve cells. A link has been found between cellular machineries
    of protein degradation and regulation of the epigenetic landscape
    in human embryonic stem cells.



    FULL STORY ==========================================================================
    Loss of ubiquitin-conjugating enzyme leads to impediment in growth
    of nerve cells. A link has been found between cellular machineries of
    protein degradation and regulation of the epigenetic landscape in human embryonic stem cells.


    ==========================================================================
    A group of scientists from CECAD, the Cluster of Excellence 'Cellular
    Stress Responses in Aging-Associated Diseases,' have found a mechanism by
    which neurodevelopmental diseases concerning neurons can be explained:
    The loss of a certain enzyme, UBE2K, impeded the differentiation of
    stem cells by silencing the expression of genes important for neuronal differentiation and, therefore, the development and generation of
    neurons. More specifically, UBE2K regulates the levels and activation
    of histones, key proteins that pack and organize the DNA, regulating the expression of genes. Being part of the epigenetic landscape of the cell,
    the changes made to the histones are reversible and could provide a chance
    for future developments of treatments for neurodevelopmental diseases.

    The study is available in the current issue of Communications Biology.

    Embryonic stem cells (ESCs) can replicate indefinitely while retaining
    their potential to differentiate into all other types of cells. Thus,
    nerve cells (neurons), muscle cells and all the other cells of the body
    are produced in a developing organism. Errors during this process can
    lead to congenital diseases. Degrading damaged proteins within the cell
    is an important factor in this process. Thus, the scientists studied the interaction between the proteasome, the main protagonist in terminating proteins, and the epigenetic landscape. Epigenetic landscapes are the
    heritable changes to an organism which are not determined by DNA but
    through changes to the chromatin, which can organize and silence DNA
    into tighter packages.

    Azra Fatima from CECAD studied the interactions of the histones in
    immortal human embryonic stem cells (hESCs) which have a unique chromatin architecture and especially low levels of a certain histone called H3
    which has undergone a chemical addition in the form of three methylgroups (H3K9me3).

    Histones are proteins which are part of the chromatin in cell nuclei. They build up spools around which the DNA winds, shortening it by a ratio
    of 1:10 millions. They are also responsible for regulating the gene
    expression by which genes produce proteins in the organism. In addition,
    they play an important role in the process of cellular differentiation
    in which a cell, for example an embryonic stem cell, changes into another
    type of cell with a higher degree specialization.

    They found that embryonic stem cells exhibit high expression of UBE2K (Ubiquitin-conjugating enzyme E2 K), a ubiquitin-conjugating enzyme. These enzymes are known for being important in the process of degradation
    of proteins. The loss of the enzyme in embryonic stem cells caused an
    increase in the levels of H3K9 trimethyltransferase SETDB1, resulting
    in higher trimethylation of H3K9, leading in turn to a repression of
    neurogenic genes during the differentiation of the stem cells. As a
    result, the loss of UBE2K impaired the ability of the stem cells to differentiate into neural progenitors a type of precursor cell that
    generate neurons and other cells of the nervous system.

    Besides H3K9 trimethylation, the scientists found that UBE2K binds histone
    H3 to induce its polyubiquitination and degradation by the 26S proteasome.

    Notably, ubc-20, the worm orthologue of UBE2K, also regulates both
    histone H3 levels and H3K9 trimethylation in the germ cells of the model organism C.

    elegans. 'Our results indicate that UBE2K crosses evolutionary boundaries
    to promote histone H3 degradation and reduce H3K9me3 repressive marks
    in immortal cells like human embryonic stem cells and germline cells,"
    says Fatima.

    'We found a link between the ubiquitin-proteasome system and epigenetic regulation in immortal stem cells,' Fatima concluded. 'It would be also interesting to see if UBE2K regulates the epigenetic state in other cell
    types like cancer cells.' David Vilchez, the corresponding author of the manuscript, added: 'We believe that our findings can have important implications to understand the development of the human brain.'
    By precisely regulating the levels of UBE2K it would be possible
    to determine the cell type specific epigenetic landscapes. Different
    diseases like Huntington's disease are associated with alterations in epigenetic marks. Since the epigenetic marks are reversible, it will be interesting to study if the epigenetic status of pluripotent stem cells
    from patients can be modulated by controlling the proteasome system and
    UBE2K. In order to correct the disease phenotype, novel strategies could
    be designed to correct epigenetic alterations in early developmental
    stages and thus provide a potential treatment for diseases.


    ========================================================================== Story Source: Materials provided by University_of_Cologne. Note: Content
    may be edited for style and length.


    ========================================================================== Journal Reference:
    1. Azra Fatima, Dilber Irmak, Alireza Noormohammadi, Markus
    M. Rinschen,
    Aniruddha Das, Orsolya Leidecker, Christina Schindler, Vi'ctor
    Sa'nchez- Gaya, Prerana Wagle, Wojciech Pokrzywa, Thorsten Hoppe,
    Alvaro Rada- Iglesias, David Vilchez. The ubiquitin-conjugating
    enzyme UBE2K determines neurogenic potential through histone H3
    in human embryonic stem cells. Communications Biology, 2020; 3
    (1) DOI: 10.1038/s42003-020- 0984-3 ==========================================================================

    Link to news story: https://www.sciencedaily.com/releases/2020/06/200603122942.htm https://www.sciencedaily.com/releases/2020/06/200603122942.htm

    --- up 19 weeks, 1 day, 3 hours, 31 minutes
    * Origin: -=> Castle Rock BBS <=- Now Husky HPT Powered! (1337:3/111)